Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BIO
BIO
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
Xconomy
Fri, 09/18/20 - 10:56 am
drug pricing
innovation
Donald Trump
executive order
BIO
Trump's meeting with pharma execs canceled after drug lobbies refuse to show up
Beckers Hospital Review
Tue, 07/28/20 - 10:35 am
Donald Trump
lobbyists
BIO
drug pricing
executive orders
Biotechnology trade group taps former Biogen CEO as its coronavirus czar
Reuters
Sat, 02/29/20 - 06:48 pm
BIO
George Scangos
Biogen
coronavirus
COVID-19
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO
Xconomy
Fri, 11/29/19 - 02:36 pm
biotech
venture capital
BIO
Greenwood: In Pharma Value Chain, PBMs Manage to Benefit
BIOTechNow
Tue, 04/9/19 - 08:28 am
BIO
PBMs
drug pricing
BIO tells SEC: do away with quarterly reports for small biotechs
Endpoints
Sat, 03/30/19 - 12:03 am
BIO
SEC
biotechs
quarterly reports
BIO Calls for Innovation in Addressing the Opioid Crisis
BioSpace
Tue, 03/12/19 - 10:03 am
BIO
innovation
opioids
opioid crisis
BIO chair: More drugmakers should pledge to not hike prices
BioPharma Dive
Thu, 12/13/18 - 07:49 pm
BIO
drug pricing
Adaptive Trial Designs: BIO, Janssen, ACRO Call for Tweaks to FDA Draft Guidance
RAPS.org
Sun, 12/2/18 - 12:31 pm
clinial trials
adaptive trial design
FDA
BIO
ACRO
Janssen
BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation
Businesswire
Thu, 11/29/18 - 10:19 am
BIO
biotech
start-ups
taxes
R&D
BIO Has Big Diversity Goals. Does It Have the Means to Reach Them?
Xconomy
Thu, 10/11/18 - 11:02 pm
BIO
diversity
gender gap
BIO warns members: No more raucous after-hours events — and start putting women in senior posts, now
Endpoints
Thu, 10/4/18 - 12:48 pm
BIO
women
diversity
gender gap
BIO, Allergan and Roche Call for FDA Flexibility With Patient Experience Data
RAPS.org
Wed, 09/12/18 - 07:16 pm
BIO
Allergan
Roche
FDA
patient experience data
PhRMA, BIO: Disclosing drug prices in ads not beneficial to patients
BioCentury
Fri, 08/24/18 - 10:33 pm
PhRMA
BIO
drug prices
drug ads
Merck, GSK, BIO and Pew Comment on Draft Guidance on LPAD Approval Pathway
RAPS.org
Wed, 08/15/18 - 10:30 pm
Merck
GSK
BIO
Pew Charitable Trusts
LPAD pathway
Top Democrat demands PhRMA, BIO do more on gender issues after party with topless dancers
Stat
Fri, 06/29/18 - 09:48 am
PhRMA
BIO
sexual harassment
Judge denies PhRMA, BIO jab at Nevada law
BioPharma Dive
Wed, 09/20/17 - 11:05 pm
PhRMA
BIO
Nevada
drug pricing
PhRMA, BIO push back against Nevada patent law
BioPharma Dive
Tue, 09/5/17 - 09:37 am
PhRMA
BIO
Nevada
patents
SB539
trade secrets
innovation
Pharma groups to FDA: Stop that new off-label rule in its tracks
Fierce Pharma
Tue, 02/28/17 - 10:04 am
FDA
off-label
BIO
PhRMA
Tired of playing 'scapegoat' in a tough election year, BIO gears up for a fight
Fierce Pharma
Fri, 06/10/16 - 09:23 am
BIO 2016
BIO
PhRMA
2016 Presidential election
Pages
« first
‹ previous
1
2
3
next ›
last »